Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
22/09/2025 23:56
Sept 23 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX: ALGORAE SIGNS EXCLUSIVE LICENSE AGREEMENT WITH SAKAR DEAL FOR LAUNCHING 5 GENERIC ONCOLOGY MEDICINES INTO AUSTRALIAN, NZ MARKETS Further company coverage: 1AI.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar